Dr. Mansukh Mandaviya interacted with representatives of Japanese Pharma Companies and members of the Japan Pharmaceutical Manufacturers Association (JPMA), at the Indian Embassy in Tokyo today. Mr Junichi Shiraishi, Director General, JPMA and Dr Sachiko Nakagawa, Managing Director, JPMA were present in the discussions.
Addressing the gathering, Dr Mandaviya stated that “India is recognized as a global pharmaceutical hub, with its industry playing a pivotal role in improving health outcomes worldwide by serving as a dependable supplier of affordable and high-quality drugs”. He highlighted that “India has played a significant role in enhancing global accessibility by providing approximately 60% of the global vaccine supply and 20-22% of generic exports. In the battle against the COVID-19 pandemic, India has supplied essential drugs to around 185 countries”.
Copyright © 2017 Indian Grapevine a unit of Integrated Media Enterprises
